The close relationship between postprandial remnant metabolism and insulin resistance

Atherosclerosis

Volumn 172, Issue 1, 2004, Pages 151-154

  Funada, Jun Ichi ^a   Sekiya, Michihito ^a   Otani, Takashi ^a   Watanabe, Kouki ^b   Sato, Makoto ^a   Akutsu, Hiroshi ^a  

^a National Hospital Organization Ehime Medical Center   (Japan)

^b Department of Internal Medicine   (Japan)

Author keywords

HOMA R; Insulin resistance; Postprandial hyperlipidemia; Remnant like particle (RLP) cholesterol

Indexed keywords

LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DETERMINATION; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY FAT; BODY MASS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LOADING TEST; MALE; MULTIPLE REGRESSION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0347355494     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.09.016     Document Type: Article

References (23)

1. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
2. Phillips N.R., Waters D., Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88:1993;2762-2770.
3. Karpe F., Steiner G., Uffelman K., Olivercrona T., Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 106:1994;83-97.
4. Patsch J.R., Miesenböck G., Hopferwieser T., Mühlberger V., Knapp E., Dunn J.K.et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12:1992;1336-1345.
5. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M.et al. Cholesterol in remnant-like lipoproteins in human serum monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels. Clin. Chim. Acta. 223:1993;53-71.
6. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation. 60:1979;473-485.
7. Havel R.J. Postprandial hyperlipidemia and remnant lipoprotein. Curr. Opin. Lipidol. 5:1994;102-109.
8. Jeppesen J., Hollenbeck C.B., Zhou M.Y., Coulston A.M., Jones C., Chen Y.D.I.et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler. Thromb. Vasc. Biol. 15:1995;320-324.
9. Abbasi F., Mclaughlin T., Lamendola C., Yeni-komshian H., Tanaka A., Wang T.et al. Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. J. Clin. Endocrinol. Metab. 84:1999;3903-3906.
10. Watanabe N., Taniguchi T., Taketoh H., Kitagawa Y., Namura H., Yoneda N.et al. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care. 22:1999;152-156.
11. Ohnishi H., Saitoh S., Tagaki S., Ohta J., Isobe T., Kikuchi Y.et al. Relationship between insulin-resistance and remnant-like particle cholesterol. Atherosclerosis. 164:2002;167-170.
12. Taniguchi A., Fukushima M., Sakai M., Miwa K., Makita T., Nagata I.et al. Remnant-like particle cholesterol, triglyceride, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care. 23:2000;1766-1769.
13. Karpe F., Boquist S., Tang R., Bond G.M., Faire U., Hamsten A. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J. Lipid. Res. 42:2001;17-21.
14. Funada J., Sekiya M., Hamada M., Hiwada K. Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction. Circ. J. 66:2002;127-132.
15. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-509.
16. Oimatsu H., Saitoh S., Ura N., Shimamoto K. A practical index for evaluation of insulin resistance. J. Jpn. Diabetes Soc. 43:2000;205-213. (in Japanese).
17. Campos E., Nakajima K., Tanaka A., Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J. Lipid Res. 33:1992;369-380.
18. Doi H., Kugiyama K., Ohgushi M., Sugiyama S., Matsumara T., Ohta Y.et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 137:1998;341-349.
19. Doi H., Kugiyama K., Oka H., Sugiyama S., Ogata N., Koide S.et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation. 102:2000;670-676.
20. Sakata K., Miho N., Shirotani M., Yoshida H., Takada Y., Takada A. Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis. 136:1998;225-231.
21. Inoue T., Saniabadi A.R., Matsunaga R., Hoshi K., Yaguchi I., Morooka S. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. Atherosclerosis. 139:1998;363-367.
22. Kugiyama K., Doi H., Takazoe K., Kawano H., Soejima H., Misumi K., Kawano H.et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 99:1999;2858-2860.
23. Ai M., Tanaka A., Ogita K., Sekine M., Numano F., Numano F.et al. Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 Diabetes. J. Am. Coll. Cardiol. 38:2001;1628-1632.